|
Recent Developments |
|
05-MAR-12
Syncom Formulations India has announced on Friday that it is engaged in the business of manufacturing, dealing, trading of pharmaceutical products and the exporting to various countries. In order to expand its geographical presence, company has incorporated
... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 30-Sep-2017(6) | 31-Mar-2016(12) | 31-Mar-2015(12) | | Net sales | 799.42 | 1819.06 | 1710.43 | | Other Income | 18.26 | 26.68 | 19.78 | | Total Income | 817.68 | 1845.74 | 1730.21 | | Cost of goods sold | 748.83 | 1672.95 | 1552.31 | | OPBDIT | 68.85 | 172.79 | 177.90 | | PAT | 40.32 | 103.55 | 97.57 | | Gross Block | - | - | - | | Equity capital | - | 780.65 | 780.65 | | EPS (Rs.) | - | - | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 8.4 | 9.4 | 10.3 | | Net margin (% of OI) | 4.9 | 5.6 | 5.6 |
|
|
Detailed Financials
|
|
|
|
|
